Comera Life Sciences Holdings, Inc. Quarterly Cost of Revenue in USD from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Comera Life Sciences Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2021 to Q3 2023.
  • Comera Life Sciences Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $42K, a 31.2% decline year-over-year.
  • Comera Life Sciences Holdings, Inc. Cost of Revenue for the twelve months ending September 30, 2023 was $265K.
  • Comera Life Sciences Holdings, Inc. annual Cost of Revenue for 2022 was $210K, a 30.7% increase from 2021.
  • Comera Life Sciences Holdings, Inc. annual Cost of Revenue for 2021 was $161K, a 54.2% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $265K $42K -$19K -31.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $284K $56K +$1.5K +2.75% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $282K $117K +$72K +162% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $210K $50.4K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-17
Q3 2022 $61K +$12.6K +26.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $54.5K -$3.02K -5.25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $44.5K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $48.4K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $57.6K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.